openPR Logo
Press release

Neuropathic Pain Market to Exceed US$ 8.3 Bn in 2024

05-07-2018 01:57 PM CET | Health & Medicine

Press release from: Persistence Market Research pvt ltd

According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast period 2016–2024 and reach US$ 8.3 Bn by the end of 2024.

Market dynamics

Rising occurrence of diabetes and cancer, new treatment options to treat neuropathic pain, growth in the number of pain management centers, and increasing demand for neuropathic pain treatment are major factors driving revenue growth of the global neuropathic pain market currently. Other factors driving market growth include rapid product launches for the treatment of neuropathic pain, a growing awareness among patients for the treatment of neuropathic pain, and an increasing demand for generic drugs.

Pharmaceutical companies are focusing on developing new and improved drugs to fulfil unmet needs of patients suffering from neuropathic pain. However, challenges such as severe side effects of opioids and steroids and rising costs of branded drugs are likely to restrain the growth of the global neuropathic pain market in the next eight years.

Request to Sample of Report @  https://www.persistencemarketresearch.com/samples/4149

Market forecast

The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The less side effects of this drug is expected to contribute to its growing popularity. The Anticonvulsants segment is projected to reach a market valuation of US$ 3.3 Bn by 2024 end. The Tricyclic Antidepressant segment is also likely to emerge as the most preferred drug class type for both patients and physicians globally over the forecast period.

On the basis of indication, the market has been segmented into Diabetic Neuropathy, Chemotherapy Induced Peripheral Neuropathy, and Others. The highest market share is held by the Diabetic Neuropathy segment, followed by the Chemotherapy Induced Peripheral Neuropathy segment. The Diabetic Neuropathy segment is estimated to account for the highest value share of 46.7% of the global neuropathic pain market by 2016 end. The Chemotherapy Induced Peripheral Neuropathy segment is estimated to account for 42.4% revenue share in the global neuropathic pain market by 2016 end.

Request Report Multiple Chapter @ https://www.persistencemarketresearch.com/multiple-chapter/4149

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. This report assesses trends driving each market segment and offers analysis and insights into the potential of neuropathic pain in specific regions. North America is estimated to dominate the global neuropathic pain market with maximum value share of the overall market by the end of 2016. The North America neuropathic pain market is estimated to increase at a CAGR of 5.8% through 2024. Emergence of several regional market players, a robust distribution network, and well-developed healthcare infrastructure support in North America are some of the key factors driving revenue growth of the neuropathic pain market in North America.

For more information @ https://www.prnewswire.com/news-releases/global-neuropathic-pain-market-to-reach-us-83-bn-by-2024-end-developing-economies-expected-to-fuel-revenue-growth-603764096.html

Competitive landscape

The global neuropathic pain market report profiles some of the top players operating in the global neuropathic pain market such as Baxter Healthcare Corporation, Depomed, Inc., GlaxoSmithKline PLC, Biogen Idec, Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Eli Lily and Company, and Bristol Myers Squibb. These companies are primarily focusing on producing improved drugs for the treatment of neuropathic pain to gain maximum share in the global neuropathic pain market.

Get full report now @ https://www.persistencemarketresearch.com/checkout/4149

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market to Exceed US$ 8.3 Bn in 2024 here

News-ID: 1041668 • Views: 199

More Releases from Persistence Market Research pvt ltd

Osteoarthritis Treatment Market Analysis By 2025 | Top Key Players are Johnson & …
Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among
Soft Tissue Repair Market Opportunity By 2024 | Top Key Players are Baxter, B. B …
Soft tissue repair is a process of replacement of destroyed or injured tissue by healthy tissue. One of the key factors driving the market is the rise in a number of accidents and accidental injuries. This is leading to the soft tissue injuries in ligaments, muscle, and tendons. Soft tissue injuries are being treated with soft tissue fixation devices and scaffolds. Increasing number of sports injuries is also driving the
Biosensor Market Forecast By 2020 | Top Key Players are Abbott Laboratories, Inc …
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 22,551.2 million in 2020. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/3589 Globally, the
Growing Usage in Non-medical Sectors to Create Promising Prospects for Medical & …
Persistence Market Research has estimated the global market for medical & industrial gloves at US$ 12,868.6 Mn by the end of 2026, exhibiting robust expansion at a CAGR of 7.9% over 2018–2026. According to the latest market outlook released by the company, the global Medical & Industrial Gloves Market holds promising growth prospects over the next eight years. The market will benefit from multiple innovations through intense research and

All 5 Releases


More Releases for Neuropathy

Diabetic Neuropathy Market Opportunity Analysis, 2018-2026
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market Opportunity Analysis, 2018-2026
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018
"The Report Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Diabetic Peripheral Neuropathy Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. "Diabetic neuropathy is nerve damage caused by diabetes. The type
Diabetic Neuropathy Market - Global Industry Analysis 2024
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market - Global Industry Analysis 2025
Market Overview Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or tingling in the feet pain or discomfort in the feet or legs-including prickly,